SINTX Technologies Inc is an advanced biomaterials company that develops, manufactures, and commercializes patented and proprietary silicon nitride ceramic biomaterials, composites, devices, and related ceramics technologies for medical and other specialized industrial applications. Our key business segments of focus are the use of silicon nitride for antipathogenic, biomedical, orthopedic, and surgical applications. SINTX has over 20 years' experience innovating silicon nitride technologies and operates under a quality management system certified to ISO 13485:2016 and AS9100D, with a product portfolio that includes insulators for Tier 1 aerospace suppliers, the FDA-cleared SiNAPTIC® Foot & Ankle Osteotomy Wedge System for reconstructive surgery, OEM manufacturing of FDA-cleared spinal implants, and the SiNERGY™ technology platform being developed for biocomposite and 3D printing applications. Originally incorporated as Amedica Corporation, we have operated as SINTX Technologies since 2018 and are headquartered in Salt Lake City, Utah.
Looking for a particular SINTX Technologies employee's phone or email?
The SINTX Technologies annual revenue was $11.2 million in 2026.
Eric Olson is the Chairman of the Board of SINTX Technologies.
26 people are employed at SINTX Technologies.
SINTX Technologies is based in Salt Lake City, Utah.
The NAICS codes for SINTX Technologies are [334, 33451, 33, 42, 3345].
The SIC codes for SINTX Technologies are [384, 38].